Current and Future Considerations for the Use of Checkpoint Inhibitors in Gastroesophageal Cancers

Get an expert&rsquo s take on recent advances and current best practices in the use of immune checkpoint inhibitors for treating gastroesophageal cancers in this program that includes live workshops an on-demand Webcast and downloadable slideset.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Merck Sharp & Dohme Corp.